PMID: 11929390Apr 4, 2002Paper

Antibiotic prophylaxis prior to endoscopic retrograde cholangiopancreatography in patients with obstructive jaundice: is it worth the cost?

Alimentary Pharmacology & Therapeutics
B F ThompsonC M Wilcox

Abstract

There are few published data concerning the economic impact of antibiotic prophylaxis prior to endoscopic retrograde cholangiopancreatography in the setting of biliary obstruction. To perform decision analysis to determine the costs of prophylaxis in patients undergoing endoscopic retrograde cholangiopancreatography for obstructive jaundice. A decision analysis model was constructed. The probability of biliary sepsis, death and endoscopic retrograde cholangiopancreatography complications was obtained from the medical literature and from a retrospective analysis of our own experience. Costs were obtained from Medicare reimbursement at our institution. The strategies evaluated were endoscopic retrograde cholangiopancreatography with and without single-dose antibiotic prophylaxis. We compared the total costs, number of episodes of cholangitis and deaths associated with each strategy. Based on published data and the results of our retrospective analysis, the strategy of administering single-dose prophylactic antibiotics prior to endoscopic retrograde cholangiopancreatography in patients with obstructive jaundice resulted in lower total costs, fewer episodes of cholangitis and fewer deaths compared to a strategy of not administering...Continue Reading

References

Sep 1, 1991·The Journal of Hospital Infection·C G AlveynG Tillotson
Nov 1, 1991·Gastroenterology·S MotteM Cremer
Sep 26, 1996·The New England Journal of Medicine·M L FreemanA M Pheley
Aug 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R FinkelsteinS Eidelman
Mar 10, 2001·The American Journal of Gastroenterology·E MasciP A Testoni

❮ Previous
Next ❯

Citations

Mar 17, 2006·Current Treatment Options in Gastroenterology·Mamta K Jain, Rajeev Jain
Oct 1, 2009·The Indian Journal of Surgery·Rajendra Desai, Bahaman N Shokouhi
Jun 1, 2005·Seminars in Interventional Radiology·Ali Zarrinpar, Robert K Kerlan
Apr 9, 2010·The New England Journal of Medicine·Muhammed F DawwasGuruprasad P Aithal
Jun 5, 2004·Journal of Vascular and Interventional Radiology : JVIR·J Mark RyanTony P Smith
Dec 7, 2007·Gastrointestinal Endoscopy·Peter B CottonJoseph Romagnuolo
May 8, 2007·Techniques in Vascular and Interventional Radiology·P Beddy, J M Ryan
Jan 1, 2014·Journal of Paediatrics and Child Health·Jie Ying LeeMarion Aw
Sep 19, 2006·Journal of Hepatology·Hasan KulaksizAdolf Stiehl
Dec 3, 2014·Clinical Radiology·J A SutcliffeR Uberoi
Sep 10, 2016·Scandinavian Journal of Gastroenterology·Jian-Shan CaiYin Bao-Bing
Dec 17, 2005·European Journal of Gastroenterology & Hepatology·Juergen PohlAdolf Stiehl
Jan 17, 2012·Scandinavian Journal of Gastroenterology·Liesbeth M KagerCyriel Y Ponsioen
Dec 14, 2016·Middle East Journal of Digestive Diseases·Rasoul SotoudehmaneshShadi Kolahdoozan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery
C C WuT J Liu
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
Eduardo M Targarona, Gali Even Bendahan
© 2022 Meta ULC. All rights reserved